Premature ovarian failure and dehydroepiandrosterone

Author affiliations
  • PyroGenesis (Greece) ROR

Fertility and Sterility, 91(2), 644-646, 2008

DOI 10.1016/j.fertnstert.2007.11.055 PMID 18321501

Abstract

In the light of similarities between premenstrual syndrome and toxaemia, and the fact that treatment of the former with progesterone not only relieved the symptoms (Greene and Dalton, 1953) but also prevented the development of edema, hypertension, and albumin

Topics

premature ovarian failure DHEA dehydroepiandrosterone treatment, DHEA supplementation premature ovarian insufficiency, dehydroepiandrosterone ovarian reserve diminished fertility, premature ovarian failure hormonal therapy options, DHEA premature menopause reproductive outcomes, adrenal androgen supplementation ovarian failure, dehydroepiandrosterone fertility treatment poor ovarian response, premature ovarian insufficiency androgen supplementation, DHEA ovarian function restoration premenopause, Mamas DHEA premature ovarian failure fertility sterility
PMID 18321501 18321501 DOI 10.1016/j.fertnstert.2007.11.055 10.1016/j.fertnstert.2007.11.055

Cite this article

Mamas, L., & Mamas, E. (2009). Premature ovarian failure and dehydroepiandrosterone. *Fertility and sterility*, *91*(2), 644-646. https://doi.org/10.1016/j.fertnstert.2007.11.055

Related articles